Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- PR Newswire
- Venture Capital
News of the day
Spherics, Inc. Offers Extended Release Formulation for Sustained and Stable Levodopa Levels
25th August 2008 WELLESLEY HILLS, Massachusetts, August 25 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. ("Finn"), Assignee of the assets of Spherics, Inc. ("Spherics") for the benefit of creditors, announced today that all pharmaceutical intellectual property will be sold at a sealed bid auction on October 10, 2008. SRx-501 is an extended release formulation of Levodopa-Carbidopa that is the current gold standard treatment for Parkinson's disease, with global sales estimated at approximately US$250 million.... moreESBATech Raises Additional CHF 23M (USD 22M), Extending Series B Venture Financing
7th August 2008 ZURICH, Switzerland, August 7 /PRNewswire/ -- ESBATech AG, a leading developer of antibody fragment therapeutics, today announced that the company has raised an additional CHF 23M (USD 22M, EUR 14M) in an extended Series B venture round to expand its development pipeline. A global syndicate of current investors participated in this round including SV Life Sciences, Clarus Ventures, HBM BioVentures, HBM BioCapital, Novartis Bioventures, BioMedinvest and VI Partners. This funding builds on... moreLaunch of Fountain Healthcare Partners, a Life Science Venture Capital Firm
29th April 2008 DUBLIN and NEW YORK, April 29 /PRNewswire/ -- Fountain Healthcare Partners ("Fountain") today launches and announces the first close of its inaugural fund, Fountain Healthcare Partners I, with EUR75 (US$117) million of committed capital. The fund is the largest dedicated life science (specialty pharmaceuticals, biotechnology, medical devices and diagnostics) venture capital ("VC") firm based in Ireland. It is also one of the largest emerging manager VC funds raised in the life science... more PR Newswire search
Most viewed
- Breathe Technologies, Inc. Closes on US$15 Million in Venture Funding Led by Kleiner Perkins Caufield & Byers
- Launch of Fountain Healthcare Partners, a Life Science Venture Capital Firm
- ESBATech Raises Additional CHF 23M (USD 22M), Extending Series B Venture Financing
- Spherics, Inc. Offers Extended Release Formulation for Sustained and Stable Levodopa Levels
More recent news
Breathe Technologies, Inc. Closes on US$15 Million in Venture Funding Led by Kleiner Perkins Caufield & Byers
26th March 2008 FREMONT, California, March 26 /PRNewswire/ -- Breathe Technologies, Inc., which is developing innovative,
patient-friendly medical devices to treat respiratory problems associated
with Chronic...
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us